ClinConnect ClinConnect Logo
Search / Trial NCT06581133

Sleep Disruption Pattern - Epilepsy Monitoring Unit

Launched by DUKE UNIVERSITY · Aug 29, 2024

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Epilepsy Monitoring Unit

ClinConnect Summary

This clinical trial is looking at how sleep disruptions can affect seizures in people with epilepsy who have not been able to control their seizures with medication. Researchers want to find out if waking patients up with an alarm during sleep could lead to earlier seizures. This could help doctors understand more about seizure patterns and potentially decrease the amount of time patients need to stay in the hospital for monitoring.

To be part of this study, participants should be between 14 and 60 years old, be undergoing monitoring in a special epilepsy unit for surgery evaluations, and have seizures occurring 2 to 3 times a week. It's important that sleep is a known trigger for their seizures. Participants can expect to stay in a hospital where their sleep and seizure activity will be closely monitored as part of the research. The goal is to gather valuable information that could improve care for those with epilepsy.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age 14 to 60 years
  • EMU monitoring for presurgical evaluations
  • Average 2-3 seizures per week based on pre-admission seizure diary
  • Sleep as a known seizure trigger
  • Exclusion Criteria:
  • - Multiple seizures a day based on pre-admission seizure diary

About Duke University

Duke University, a leading academic and research institution located in Durham, North Carolina, is renowned for its commitment to advancing healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, Duke conducts a wide array of clinical trials aimed at developing cutting-edge therapies and improving patient outcomes across various medical fields. The university's Clinical Research Institute provides comprehensive support for trial design, implementation, and regulatory compliance, ensuring that all research adheres to the highest ethical and scientific standards. Duke’s dedication to translating research findings into effective clinical practices underscores its role as a pivotal contributor to the global medical community.

Locations

Patients applied

0 patients applied

Trial Officials

Birgit Frauscher, MD PD

Principal Investigator

Duke University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported